|

AZD0901 Clinical Trials

5 actively recruiting trials across 4 locations

Also known as: CMG901, Sonesitatug Vedotin

Pipeline

Phase 2: 4Phase 3: 1

Top Sponsors

  • AstraZeneca5

Indications

  • Cancer5
  • Gastric Cancer4
  • Gastroesophageal-junction Cancer3
  • Gastroesophageal Adenocarcinoma1
  • Pancreatic Ductal Adenocarcinoma1

Other1 trial

A Study to Investigate the Effects of AZD0901 Monotherapy in Adult Participants With 2L+ Advanced or Metastatic Gastric or GEJ Adenocarcinoma Expressing CLDN18.2
Phase 2

Birmingham, Alabama1 trial

AZD0901 Compared With Investigator's Choice of Therapy in Participants With Second- or Later-line Advanced or Metastatic Gastric or Gastroesophageal Junction Adenocarcinoma Expressing Claudin18.2

Research Site

Phase 3

Los Angeles, California1 trial

Novel Combinations in Participants With Locally Advanced Unresectable or Metastatic Gastric or Gastroesophageal Junction Adenocarcinoma

Research Site

Phase 2

Orange, California1 trial

AZD0901 in Participants With Advanced Solid Tumours Expressing Claudin18.2

Research Site

Phase 2

Newark, Delaware1 trial

A Study of Novel Agents or Combinations as Perioperative Treatment in Participants With Locally Advanced Resectable Gastroesophageal Adenocarcinoma

Research Site

Phase 2

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.